Aethlon Medical, Inc. (AEMD) Earnings History
Annual and quarterly earnings data from 1997 to 2025
Loading earnings history...
AEMD EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
AEMD Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | 100.0% | -2072.0% | -2094.9% |
| 2022 | 100.0% | -3542.5% | -3540.9% |
| 2021 | 100.0% | -1197.3% | -1196.6% |
Download Data
Export AEMD earnings history in CSV or JSON format
Free sign-in required to download data
Aethlon Medical, Inc. (AEMD) Earnings Overview
As of May 8, 2026, Aethlon Medical, Inc. (AEMD) reported trailing twelve-month net income of -$2.03B, reflecting -76.5% year-over-year growth. The company earned $-2463.47 per diluted share over the past four quarters.
Looking at the long-term picture, AEMD's historical earnings data spans multiple years. The company achieved its highest annual net income of -$1,534 in fiscal 1997.
Aethlon Medical, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including XTLB (-$1M net income, -227.7% margin), EKSO (-$16M net income, -91.4% margin), PRTH ($56M net income, 5.8% margin), AEMD has comparable earnings metrics. Compare AEMD vs XTLB →
AEMD Earnings vs Peers
Earnings metrics vs comparable public companies
AEMD Historical Earnings Data (1997–2025)
29 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$13M | -9.7% | -$9M | $-85.80 | - | - |
| 2024 | -$12M | -1.5% | -$13M | $-48.60 | - | - |
| 2023 | -$12M | -15.5% | -$12M | $-58.60 | -2094.9% | -2072.0% |
| 2022 | -$10M | -32.1% | -$10M | $-70.60 | -3540.9% | -3542.5% |
| 2021 | -$8M | -23.7% | -$8M | $-65.20 | -1196.6% | -1197.3% |
| 2020 | -$6M | -2.9% | -$6M | $-186.70 | -980.3% | -912.0% |
| 2019 | -$6M | -9.1% | -$6M | $-512.70 | -2697.9% | -2612.5% |
| 2018 | -$6M | +21.9% | -$5M | $-691.70 | -3796.2% | -3228.7% |
| 2017 | -$7M | -49.3% | -$6M | $-1410.00 | -1855.8% | -1555.3% |
| 2016 | -$5M | +28.3% | -$4M | $-988.50 | -549.5% | -494.6% |
See AEMD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AEMD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AEMD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonAEMD — Frequently Asked Questions
Quick answers to the most common questions about buying AEMD stock.
Is AEMD growing earnings?
AEMD EPS fell to $-2463.47, with earnings declining -76.5%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-2.0B.
What are AEMD's profit margins?
Aethlon Medical, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are AEMD's earnings?
AEMD earnings data spans 1997-2025. The declining earnings trend is -76.5% YoY. Historical data enables comparison across business cycles.